Alamast (Pemirolast Potassium) - Indications and Dosage

INDICATIONS AND USAGE

ALAMAST^® ophthalmic solution is indicated for the prevention of itching of the eye due to allergic conjunctivitis. Symptomatic response to therapy (decreased itching) may be evident within a few days, but frequently requires longer treatment (up to four weeks).

DOSAGE AND ADMINISTRATION

The recommended dose is one to two drops in each affected eye four times daily.

Symptomatic response to therapy (decreased itching) may be evident within a few days, but frequently requires longer treatment (up to four weeks).

HOW SUPPLIED

ALAMAST^® (pemirolast potassium ophthalmic solution) 0.1% is supplied as follows:

10 mL in a white, low density polyethylene bottle with a controlled dropper tip, and a white polyethylene screw cap.

NDC 68669-711-10 10 mL fill in 11 cc container

Storage

Store at 15°-25°C (59°-77°F).

Manufactured by

Santen Oy, PO Box 33
FIN-33721 Tampere, Finland

Marketed by

VISTAKON^® Pharmaceuticals, LLC                 U.S. Patent No. 5,034,230
Jacksonville, FL 32256 USA

Licensed from Mitsubishi Pharma Corporation
Japan

February 2005 Version